
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The epidemiology of cognitive function in Parkinson's disease
Meredith Bock, Caroline M. Tanner
Progress in brain research (2022), pp. 3-37
Closed Access | Times Cited: 12
Meredith Bock, Caroline M. Tanner
Progress in brain research (2022), pp. 3-37
Closed Access | Times Cited: 12
Showing 12 citing articles:
Is Citicoline Effective in Preventing and Slowing Down Dementia?—A Systematic Review and a Meta-Analysis
Maria Bonvicini, Silvia Travaglini, Diana Lelli, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 386-386
Open Access | Times Cited: 14
Maria Bonvicini, Silvia Travaglini, Diana Lelli, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 386-386
Open Access | Times Cited: 14
Neuroprotection by tetramethylpyrazine and its synthesized analogues for central nervous system diseases: a review
Fan Feng, Ding‐Qiao Xu, Shi‐Jun Yue, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Fan Feng, Ding‐Qiao Xu, Shi‐Jun Yue, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Leveraging animal models to understand non-motor symptoms of Parkinson's disease
Thomas Wichmann, Alexandra Nelson, Eileen Ruth S. Torres, et al.
Neurobiology of Disease (2025), pp. 106848-106848
Open Access
Thomas Wichmann, Alexandra Nelson, Eileen Ruth S. Torres, et al.
Neurobiology of Disease (2025), pp. 106848-106848
Open Access
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 498-498
Open Access | Times Cited: 10
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 498-498
Open Access | Times Cited: 10
The importance of social behavior in nonhuman primate studies of aging: A mini-review
Emily S. Rothwell, Sarah B. Carp, Eliza Bliss‐Moreau
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105422-105422
Closed Access | Times Cited: 8
Emily S. Rothwell, Sarah B. Carp, Eliza Bliss‐Moreau
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105422-105422
Closed Access | Times Cited: 8
Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
Jemma Kim, John V. Rider, Anne Zinselmeier, et al.
Journal of Clinical Neuroscience (2024) Vol. 126, pp. 101-107
Closed Access | Times Cited: 1
Jemma Kim, John V. Rider, Anne Zinselmeier, et al.
Journal of Clinical Neuroscience (2024) Vol. 126, pp. 101-107
Closed Access | Times Cited: 1
Salidroside improves cognitive function in Parkinson’s disease via Braf-mediated mitogen‑activated protein kinase signaling pathway
Shujin Lu, Niu Ji, Wei Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116968-116968
Open Access | Times Cited: 1
Shujin Lu, Niu Ji, Wei Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116968-116968
Open Access | Times Cited: 1
Neutrophil‐to‐lymphocyte ratio and longitudinal cognitive performance in Parkinson's disease
Jenniffer Lucero, Ashita S. Gurnani, Janice Weinberg, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 9, pp. 2301-2313
Open Access | Times Cited: 1
Jenniffer Lucero, Ashita S. Gurnani, Janice Weinberg, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 9, pp. 2301-2313
Open Access | Times Cited: 1
Effect of acceptance and commitment therapy on fear of falling and physical activity in Parkinson’s disease: a randomised controlled trial
Jiyoung Gwak, Jinse Park
BMJ Neurology Open (2024) Vol. 6, Iss. 2, pp. e000796-e000796
Open Access | Times Cited: 1
Jiyoung Gwak, Jinse Park
BMJ Neurology Open (2024) Vol. 6, Iss. 2, pp. e000796-e000796
Open Access | Times Cited: 1
Progression of cognitive impairment in Parkinson’s disease correlates with uric acid concentration
Rui-Xue Zhai, Hui Yu, Han Ma, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Rui-Xue Zhai, Hui Yu, Han Ma, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Tenuifolin suppresses mitophagy via the PINK1/Parkin pathway as a potential therapeutic approach for Parkinson's disease models
Xinyue Zhang, Menglin Yao, Ting Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Xinyue Zhang, Menglin Yao, Ting Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury
Lianyuan Feng, Aruna Sharma, Zhenguo Wang, et al.
Advances in neurobiology (2023), pp. 97-138
Closed Access
Lianyuan Feng, Aruna Sharma, Zhenguo Wang, et al.
Advances in neurobiology (2023), pp. 97-138
Closed Access